GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verastem Inc (FRA:2VSA) » Definitions » Accounts Payable & Accrued Expense

Verastem (FRA:2VSA) Accounts Payable & Accrued Expense : €20.52 Mil (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Verastem Accounts Payable & Accrued Expense?

Verastem's quarterly accounts payable & accrued expense increased from Sep. 2023 (€16.68 Mil) to Dec. 2023 (€18.63 Mil) and increased from Dec. 2023 (€18.63 Mil) to Mar. 2024 (€20.52 Mil).

Verastem's annual accounts payable & accrued expense increased from Dec. 2021 (€12.42 Mil) to Dec. 2022 (€15.14 Mil) and increased from Dec. 2022 (€15.14 Mil) to Dec. 2023 (€18.63 Mil).


Verastem Accounts Payable & Accrued Expense Historical Data

The historical data trend for Verastem's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verastem Accounts Payable & Accrued Expense Chart

Verastem Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.46 8.72 12.42 15.14 18.63

Verastem Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.93 14.46 16.68 18.63 20.52

Verastem Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


Verastem (FRA:2VSA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verastem Inc (FRA:2VSA) » Definitions » Accounts Payable & Accrued Expense
Traded in Other Exchanges
Address
117 Kendrick Street, Suite 500, Needham, MA, USA, 02494
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Verastem (FRA:2VSA) Headlines

No Headlines